← Home / CVS HEALTH Corp (CVS)
Stock Analysis
CVS HEALTH Corp (CVS)
CVS
CVS · Healthcare • Healthcare Services
107.57 +0.09%
Track CVS in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CVS price is:
52W Range Position
100%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-20 16:26 UTC
WOI Investment Thesis
Constructive
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Improving / Improving
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
98.73
↗
Break Above
Confirmation improves above resistance.
—
🎯
Next Objective
Pattern-derived target if setup continues.
117.16
×
Thesis Break
Scenario weakens below invalidation.
Below 98.73
What's Driving CVS?
📈 Technical recovery is improving
Momentum is Neutral. Watch — for confirmation and 98.73 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 98.73
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Bull Flag · Confirmed
Trigger
105.49
Target
117.16
Invalidation
101.78
Pattern
Triangle Compression / SYM / DOWN
State
Forming
Compression
83%
◎
How to read this setup
Active technical structure detected. Use the chart overlays, support, resistance and invalidation levels to manage confirmation and risk.
Price Chart
CVS · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-17
Value
Value-oriented setup
Sales and book multiples are contained.
Market Cap
$136.8B
Company size
EV
$205.8B
Debt-adjusted value
P/E
47.1
Premium
P/S
0.3
Low sales multiple
P/B
1.8
Low book multiple
EV/Sales
0.5
Low sales multiple
EV/EBIT
34.5
Reasonable
P/FCF
18.5
Reasonable
FCF Yield
5.40%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving financial execution
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
↗
Revenue Growth
Improving
●
Profitability
Improving
≈
Cash Flow
Healthy
⚖
Balance Sheet
Stretched
💵 Revenue
100.43B
↗ Improving
📈 Net Income
2.96B
↗ Improving
CVS HEALTH Corp
Healthcare • Healthcare Services
Related Opportunities